Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Cannabis

Cannabis

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Organigram Q4 Revenue Grows 83% YoY, Provides Outlook

By Vuk Zdinjak
November 29, 8:49 AM
Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) released its results for the fourth quarter and year ended August 31, 2022, revealing net revenue in FY 2022 increased 84% to $145.8 million from $79.2 million in the previous year primarily due to an increase in recreational

OGI

Read More
1 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

XS Financial’s Q3 Report Shows Consistent Growth With 108% YoY Increase In Revenue

By Maureen Meehan
November 28, 7:08 PM
XS Financial Inc. (CSE: XSF) (OTCQB: XSHLF), a specialty finance company providing CAPEX and equipment financing solutions to US cannabis companies reported its financial results late Monday for the third quarter ended September 30, 2022.  

CSE:XSF

Read More
1 minute read
  • Analyst Ratings
  • Cannabis
  • Markets
  • News
  • Price Target

Cantor Fitzgerald Maintains Neutral on SNDL, Raises Price Target to $3.6

By Benzinga Newsdesk
November 28, 3:08 PM
Cantor Fitzgerald analyst Pablo Zuanic maintains SNDL (NASDAQ:SNDL) with a Neutral and raises the price target from $3.56 to $3.6.

SNDL

Read More
2 minute read
  • Analyst Color
  • Cannabis
  • Earnings
  • M&A
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Which Cannabis Stock Is A Better Buy? Analyst’s Thoughts Post Q3 Earnings

By Jelena Martinovic
November 28, 1:41 PM
Third quarter earnings season is slowly wrapping up and analysts are tweaking their ratings accordingly. Cantor Fitzgerald analyst Pablo Zuanic kicked off the week by taking a closer look at two cannabis stocks.

CBWTF

Read More
1 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

POSaBIT Continues Expansion, Goes Live With Cannabis Point Of Sale System In Vermont

By Vuk Zdinjak
November 28, 11:49 AM
POSaBIT Systems Corporation (OTCQX: POSAF) (CSE:PBIT) has gone live with their point of sale system in the Vermont market.

CSE:PBIT

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Eurofins To Produce Incannex’ 2 CBD Medicated Chews For Treatment Of Nicotine And Opioid Addiction Disorders

By Vuk Zdinjak
November 28, 11:37 AM
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has engaged multinational contract development and manufacturing organization Eurofins Scientific (OTCPK:ERFSF) to manufacture Incannex’s two distinct medicated chewable products

ERFSF

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

Cannara Biotech Q4 Revenue Grows 84% YoY To $8.9M

By Vuk Zdinjak
November 28, 11:16 AM
Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) released its fiscal fourth quarter and fiscal year 2022 financial results for the three-month and full year periods ended August 31, 2022, revealing 2022 fiscal year revenue of CA$36 million, ($26.8 million ) a 108% increase<

LOVFF

Read More
1 minute read
  • Analyst Ratings
  • Cannabis
  • Markets
  • News
  • Price Target

Cantor Fitzgerald Maintains Neutral on Auxly Cannabis Group, Lowers Price Target to $0.03

By Benzinga Newsdesk
November 28, 9:52 AM
Cantor Fitzgerald analyst Pablo Zuanic maintains Auxly Cannabis Group (OTC:CBWTF) with a Neutral and lowers the price target from $0.08 to $0.03.

CBWTF

Read More
3 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

The Green Organic Dutchman Q3 Revenue Grows 36% YoY, Here Are The Details

By Vuk Zdinjak
November 28, 9:40 AM
The Green Organic Dutchman Holdings Ltd. (OTC: TGODF) (CSE:TGOD) released its financial results for the quarter ended September 30, 2022, revealing net revenues of CA$9.92 million ($7.38 million), a 36% increase from Q3 2021.

CSE:TGOD

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

Flora Growth Shares Trading Higher On Reported Q3 Revenue Growth Of 414% YoY

By Vuk Zdinjak
November 28, 8:48 AM
Flora Growth Corp. (NASDAQ: FLGC) released its financial and operating results for the third quarter ended September 30, 2022, revealing total revenue for the quarter was $10.8 million, an increase of 414% year over year, driven by Flora’s House of Br

FLGC

Posts pagination

Previous 1 … 348 349 350 … 449 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service